Efficacy of Fluorescence In Situ Hybridization for Detecting PML/RARA Gene Fusion in Treated and Untreated Acute Promyelocytic Leukemia
- 30 November 1994
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 69 (11), 1047-1053
- https://doi.org/10.1016/s0025-6196(12)61371-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Identification of complex t(15;17) in APL by FISHCancer Genetics and Cytogenetics, 1994
- The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALLCancer Genetics and Cytogenetics, 1993
- Molecular monitoring of the myl/retinoic acid receptor-alpha fusion gene in acute promyelocytic leukemia by polymerase chain reactionBlood, 1992
- The t(15;17) breakpoint in acute promyelocytic leukemia cluster within two different sites of the myl gene: targets for the detection of minimal residual disease by the polymerase chain reactionBlood, 1992
- Cytogenetic Studies in Acute Promyelocytic Leukemia: A Survey of Secondary Chromosomal AbnormalitiesGenes, Chromosomes and Cancer, 1991
- The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locusNature, 1990
- Molecular Analysis of Acute Promyelocytic Leukemia Breakpoint Cluster Region on Chromosome 17Science, 1990
- Cloning and characterization of the T(15;17) translocation breakpoint region in acute promyelocytic leukemiaGenes, Chromosomes and Cancer, 1990
- 15/17 TRANSLOCATION, A CONSISTENT CHROMOSOMAL CHANGE IN ACUTE PROMYELOCYTIC LEUKAEMIAThe Lancet, 1977
- Partial Deletion of Long Arm of Chromosome 17Archives of Internal Medicine, 1976